Adverum Biotechnologies Inc (ADVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2012 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 350 |
| Receivables | 1 |
| Other current assets | 29 |
| TOTAL | $380 |
| Non-Current Assets | |
| TOTAL | $N/A |
| Total Assets | $380 |
| Liabilities | |
| Current Liabilities | |
| Accounts payable and accrued liabilities | 520 |
| Accrued Expenses | 310 |
| TOTAL | $830 |
| Non-Current Liabilities | |
| Other Non-Current Liabilities | 530 |
| TOTAL | $530 |
| Total Liabilities | $1,380 |
| Shareholders' Equity | |
| Retained earnings | -3,590 |
| Other shareholders' equity | 2,490 |
| TOTAL | $-990 |
| Total Liabilities And Equity | $390 |